Air travel is increasingly accessible and rising numbers of older adults choose to fly. The prevalence of Alzheimer’s disease and related dementias (ADRD) is also expected to increase due to advances in longevity and the aging Baby Boomer population. An ADRD diagnosis does not necessarily end the desire to travel for leisure, and air travel may be necessary for family and/or care reasons. Taken together, more persons living with ADRD are expected to use air travel. This is concerning since adverse outcomes, including confusion and delirium, can be exacerbated by unfamiliar environments, such as airports and in-flight situations. Yet there is little research on air travel with this population. The current study seeks to 1) understand air travel experiences, issues, and needs of persons living with ADRD and their travel companions; and 2) identify facilitators and barriers to safe and comfortable air travel for persons living with ADRD. Persons living with ADRD (n=49)and ADRD travel companions (n=176) provided information on their air travel experiences through a nationally distributed web-survey. They traveled for family visits (80.0%) and leisure (38.0%). Both persons living with ADRD and travel companions indicated anxiety (50% and 60.7%, respectively), difficulty understanding announcements and signage (39.1%, 55.2%) and getting lost or separated (37.5%, 53.2%) as primary travel concerns. Qualitative comments identified themes of frustration with locating family restrooms and quiet spaces. Results from this study will inform ongoing efforts to develop dementia-friendly airports and improve older adult travel experiences, independence, and quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.